[{"Assets_0_Q1_USD":482232000.0,"CIK":"1023024","Country":"United States","EarningsPerShareBasic_1_Q1_USD":-0.59,"EarningsPerShareDiluted_1_Q1_USD":-0.59,"Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","Market Cap":"569805985.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":1710000.0,"NetIncomeLossConverted_1_Q1_USD":-7011000.0,"OfficialName":"ANI Pharmaceuticals Inc.","RevenuesConverted_1_Q1_USD":49774000.0,"SP500":"nan","Sector":"Health Care","StockholdersEquity_0_Q1_USD":201171000.0,"Ticker":"ANIP","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":11902000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":11902000.0,"filed":"20200507","footnote":"nan","form":"10-Q","fp":"Q1","fy":"2020.0","name":"ANI PHARMACEUTICALS INC","period":"20200331","qtrs":"0","uom":"USD"}]